Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 6/2009

01-08-2009

Implications of long-term conditions for both mental and physical health: comparison of rheumatoid arthritis and schizophrenia

Auteurs: Heidi Lempp, Graham Thornicroft, Morven Leese, Naomi Fearns, Helen Graves, Bernadette Khoshaba, Antonio Lasalvia, David Scott, Michele Tansella

Gepubliceerd in: Quality of Life Research | Uitgave 6/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

To investigate whether people with long term conditions, whatever their specific nature, need to be assessed and treated for the full range of mental, physical and social problems. Main question investigated: that rheumatoid arthritis and schizophrenia will be associated with significantly greater impairment across the subscores of the SF36 scale than in reference general population samples. Specific hypothesis tested: while rheumatoid arthritis and schizophrenia will impair both physical and mental functioning, when comparing the two groups there will be a greater difference between the physical component scores than there will be between the mental/emotional component scores of the short form health survey (SF-36).

Methods

Cross sectional comparison of SF-36 subscore profiles of cohorts of: (1) people with rheumatoid arthritis attending specialist Rheumatology outpatient clinics in five London hospitals (n = 446), and (2) people with schizophrenia treated by community psychiatric teams in four sites in Europe (n = 409).

Results

Both groups had greater impairments across the whole spectrum of mental and physical problems assessed by the SF-36 than age specific normative data for the general population. The results also support our hypothesis that, comparing the people with rheumatoid arthritis and schizophrenia, we did find that there is a greater discrepancy between the physical scales than there is between the mental/emotional scales of the SF-36.

Conclusions

These findings show that whether the primary long-term condition is presenting as physical or as mental disorder, the practitioner should ensure that the full range of physical, mental and social problems is assessed and treated.
vorige artikel Beyond Type D personality: reduced positive affect (anhedonia) predicts impaired health status in chronic heart failure
volgende artikel Health-related quality of life and help seeking among American Indians with diabetes and hypertension
Literatuur
1.
World Health Organisation. (2003). The World health report 2003—shaping the future. Geneva: WHO.
2.
Betteridge, N. (2003). Bone and joint diseases around the world. Arthritis-the greatest health, disability, and civil rights challenge: A UK and international perspective. Journal of Rheumatology Supplement, 67, 36–37.
3.
Woolf, A. D., & Shichikawa, K. (2003). The Tokyo declaration. Journal of Rheumatology Supplement, 67, 65.
4.
Lempp, H., Scott, D. L., & Kingsley, G. (2006). The personal impact of rheumatoid arthritis on patients’ identity: A qualitative study. Chronic Illness, 2, 109–120.PubMed
5.
Lempp, H., Scott, D. L., & Kingsley, G. (2006). Patients’ views on the quality of health care for rheumatoid arthritis. Rheumatology (Oxford), 45(12), 1522–1528.CrossRef
6.
Persson, L., Berglund, K., & Sahlberg, D. (1999). Psychological factors in chronic rheumatic disease—a review. The case of rheumatoid arthritis, current research and some problems. Scandinavian Journal of Rheumatology, 28(3), 137–144.PubMedCrossRef
7.
Disability Rights Commission. (2006). Equal rights: Closing the gap. London: Disability Rights Commission.
8.
Amaddeo, F., Barbui, C., Perini, G., Biggeri, A., & Tansella, M. (2007). Avoidable mortality of psychiatric patients in an area with a community-based system of mental health care. Acta Psychiatrica Scandinavica, 115(4), 320–325.PubMedCrossRef
9.
Jones, S., Howard, L., & Thornicroft, G. (2008). ‘Diagnostic overshadowing’: Worse physical health care for people with mental illness. Acta Psychiatrica Scandinavica, 118(3), 169–171.PubMedCrossRef
10.
Scott, D. L., & Lempp, H. (2006). Outcomes associated with early rheumatoid arthritis. Expert Review of Pharmacoeconomics & Outcomes Research, 6(5), 495–508.CrossRef
11.
Simpson, C., Franks, C., Morrison, C., & Lempp, H. (2005). The patient’s journey: Rheumatoid arthritis. British Medical Journal, 331, 887–889.PubMedCrossRef
12.
Scott, D. L., Smith, C., & Kingsley, G. (2005). What are the consequences of early rheumatoid arthritis for the individual? Best Practice and Research Clinical Rheumatology, 19(1), 117–136.PubMedCrossRef
13.
Sprangers, M., deRegt, E., Andries, F., van Agt, H., Bijl, R., de Boer, J., et al. (2000). Which chronic conditions are associated with better or poorer quality of life. Journal of Clinical Epidemiology, 53(9), 895–907.PubMedCrossRef
14.
Young, A., Kaduri, G., Batley, M., Kulinskaya, E., Gough, A., Norton, S., et al. (2007). Mortality in rheumatic arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford), 46, 350–357.CrossRef
15.
Goodson, N., & Symmons, D. (2002). Rheumatoid arthritis in women: Still associated with an increased mortality. Annals of Rheumatic Disease, 61, 955–956.CrossRef
16.
Symmons, D., Jones, M., Scott, D. L., & Prior, P. (1998). Long-term mortality outcome in patients with rheumatoid arthritis: Early presenters continue to do well. Journal of Rheumatology, 25, 1072–1077.PubMed
17.
Main, C., & de C Williams, A. (2002). Musculoskeletal pain. British Medical Journal, 325, 534–537.PubMedCrossRef
18.
Dickens, C., McGowan, L., Clark-Carter, D., & Creed, F. (2002). Depression in rheumatoid arthritis: A systematic review of the literature with meta-analysis. Psychosomatic Medicine, 64(1), 52–60.PubMed
19.
Fitzpatrick, R., Newman, S., Lamb, R., & Shipley, M. (1988). Social relationships and psychological well-being in rheumatoid arthritis. Social Science and Medicine, 27(4), 399–403.PubMedCrossRef
20.
Brown, G., Nicassio, P., & Wallston, K. (1989). Pain coping strategies and depression in rheumatoid arthritis. Journal of Consulting and Clinical Psychology, 57, 625–657.CrossRef
21.
Jobe, T. H., & Harrow, M. (2005). Long-term outcome of patients with schizophrenia: A review. Canadian Journal of Psychiatry, 50(14), 892–900.
22.
Saha, S., Chant, D., & McGrath, J. (2007). A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Archives of General Psychiatry, 64(10), 1123–1131.PubMedCrossRef
23.
Hawton, K., Sutton, L., Haw, C., & Deek, J. J. (2005). Schizophrenia and suicide: Systematic review of risk factors. British Journal of Psychiatry, 187, 9–20.PubMedCrossRef
24.
Woolf, A. D., & Pfleger, B. (2003). Burden of major musculoskeletal conditions. Bulletin World Health Organisation, 81(9), 646–656.
25.
Abdel-Nasser, A. M., Rasker, J. J., & Valkenburg, H. A. (1997). Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis. Seminars in Arthritis and Rheumatism, 27(2), 123–140.PubMedCrossRef
26.
Saha, S., Chant, D., & McGrath, J. (2008). Meta-analyses of the incidence and prevalence of schizophrenia: Conceptual and methodological issues. Internal Journal of Methods in Psychiatric Research, 17(1), 55–61.CrossRef
27.
Symmons, D., Turner, G., Webb, R., Asten, P., Barrett, E., Lunt, M., et al. (2002). The prevalence of rheumatoid arthritis in the UK: New estimates for a new century. Rheumatology (Oxford), 41(7), 793–800.CrossRef
28.
Newcomer, J. W., & Hennekens, C. H. (2007). Severe mental illness and risk of cardiovascular disease. Journal of the American Medical Association, 298(15), 1794–1796.PubMedCrossRef
29.
Katon, W., & Sullivan, M. (1990). Depression and chronic medical illness. Journal of Clinical Psychiatry, 51(3), 14.
30.
Newman, S., & Mulligan, K. (2000). The psychology of rheumatic diseases. Bailliere’s Clinical Rheumatology, 14(4), 773–786.PubMed
31.
Slade, M., Leese, M., Cahill, S., Thornicroft, G., & Kuipers, E. (2005). Patient-rated mental health needs and quality of life improvement. British Journal of Psychiatry, 187, 256–261.PubMedCrossRef
32.
Lasalvia, A., Bonetto, C., Malchiodi, F., Salvi, G., Parabiaghi, A., Tansella, M., et al. (2005). Listening to patients’ needs to improve their subjective quality of life. Psychology Health and Medicine, 35(11), 1655–1665.
33.
Thornicroft, G. (2006). Shunned: Discrimination against people with mental illness. Oxford: Oxford University Press.
34.
Scott, D. L., & Symmons, D. P. (2008). The role of specialists in managing established rheumatoid arthritis. Rheumatology (Oxford), 47, 237–238.CrossRef
35.
36.
Gray, R., Leese, M., Bindman, J., Becker, T., Burti, L., David, A., et al. (2006). Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial. British Journal of Psychiatry, 189, 508–514.PubMedCrossRef
37.
Wing, J. K., Babor, T., Brugha, T., Burke, J., Cooper, J. E., Giel, R., et al. (1990). SCAN: Schedules for clinical assessment in neuropsychiatry. Archives of General Psychiatry, 47(6), 589–593.PubMed
38.
Ware, J., & Sherbourn, C. (1992). The MOS, 36 item short-form health survey (SF-36). Conceptual framework and item selection. Medical Care, 30, 473–483.PubMedCrossRef
39.
Leese, M., Schene, A., Koeter, M., Meijer, K., Bindman, J., Mazzi, M., et al. (2008). SF-36 scales, and simple sums of scales, were reliable quality-of-life summaries for patients with schizophrenia. Journal of Clinical Epidemiology, 61(6), 588–596.PubMedCrossRef
40.
Everitt, B., & Dunn, G. (2001). Applied multivariate data analysis (2nd ed.). London: Hodder Arnold.
41.
Cohen, J. (1992). A power primer. Psychological Bulletin, 112(1), 155–159.CrossRef
42.
Tabachnik, B. G., & Fidell, L. S. (2006). Using multivariate statistics (5th ed.). New York: Harper & Row.
43.
Ware, J. E., & Kosinski, M. (2001). SF-36 physical and mental health summary scales: A manual for users of version 1 (2nd ed.). Lincoln, RI: Quality Metric, Inc.
44.
Ware, J., Snow, K., & Kosinski, M. (1993). SF-36 Health survey manual and interpretation guide. Boston, MA: New England Medical Center, The Health Institute.
45.
LeFort, S. M. (1993). The statistical versus clinical significance debate. Image: Journal of Nursing Scholarship, 25(1), 57–62.CrossRef
46.
Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12–19.PubMedCrossRef
47.
Greenstein, G. (2003). Clinical versus statistical significance as they relate to the efficacy of periodontal therapy. Journal of the American Dental Association, 134, 583–591.PubMed
48.
Thornicroft, G., & Rose, D. (2005). Health service research: Is there anything to learn from mental health? Journal of Health Service Research Policy, 10(1), 1–2.CrossRef
49.
Duru, G., & Fantino, B. (2008). The clinical relevance of changes in the Montgomery-Asberg depression rating scale using the minimum clinically important difference approach. Current Medical Research and Opinion, 24, 1329–1335.PubMedCrossRef
50.
Beaton, D. E., Boers, M., & Wells, G. A. (2002). Many faces of the minimal clinically important difference (MICD): A literature review and directions for future research. Current Opinion in Rheumatology, 14, 109–114.PubMedCrossRef
51.
Kosinski, M., Zhao, S. Z., Dedhiya, S., Osterhaus, J. T., & Ware, J. E., Jr. (2000). Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis and Rheumatism, 43, 1478–1487.PubMedCrossRef
52.
Kosinski, M., Kujawski, S. C., Martin, R., Wanke, L. A., Buatti, M. C., Ware, J. E., Jr, et al. (2002). Health-related quality of life in early rheumatoid arthritis: Impact of disease and treatment response. American Journal of Managed Care, 8, 231–240.PubMed
53.
Tugwell, P., Wells, G., Strand, V., Maetzel, A., Bombardier, C., Crawford, B., et al. (2000). Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: Sensitivity and relative efficiency to detect a treatment effect in a 12-month, placebo-controlled trial. Leflunomide rheumatoid arthritis investigators group. Arthritis and Rheumatism, 43, 506–514.PubMedCrossRef
54.
Veehof, M. M., ten Klooster, P. M., Taal, E., van Riel, P. L., & van de Laar, M. A. (2008). Comparison of internal and external responsiveness of the generic medical outcome study short form-36 (SF-36) with disease-specific measures in rheumatoid arthritis. The Journal of Rheumatology, 35, 610–617.PubMed
55.
Ware, J. E., & Kosinski, M. (2003). SF-36 physical and mental health summary scales. A manual for users of version 1 (2nd ed.). Lincoln Rhode Island: Quality Metric Inc.
56.
Bowling, A., Bond, M., Jenkinson, C., & Lamping, D. L. (1999). Short form 36 (SF-36) health survey questionnaire: Which normative data should be used? Comparisons between the norms provided by the Omnibus survey in Britain, the health survey for England and the Oxford healthy life survey. Journal of Public Health Medicine, 21(3), 255–270.PubMedCrossRef
57.
Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Jr., Aaronson, N. K., Mosconi, P., et al. (2004). Health-related quality of life associated with chronic conditions in eight countries: Results from the international quality of life assessment (IQOLA) Project. Quality of Life Research, 13(2), 283–298.PubMedCrossRef
58.
Bazzichi, L., Maser, J., Piccinni, A., Rucci, P., Del, D. A., Vivarelli, L., et al. (2005). Quality of life in rheumatoid arthritis: Impact of disability and lifetime depressive spectrum symptomatology. Clinical and Experimental Rheumatology, 23(6), 783–788.PubMed
59.
Birtane, M., Uzunca, K., Tastekin, N., & Tuna, H. (2007). The evaluation of quality of life in fibromyalgia syndrome: A comparison with rheumatoid arthritis by using SF-36 health survey. Clinical Rheumatology, 26(5), 679–684.PubMedCrossRef
60.
Uhlig, T., Loge, J. H., Kristiansen, I. S., & Kvien, T. K. (2007). Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population. Journal of Rheumatology, 34(6), 1241–1247.PubMed
61.
Alishiri, G. H., Bayat, N., Fathi, A. A., Tavallaii, S. A., Assari, S., & Moharamzad, Y. (2008). Logistic regression models for predicting physical and mental health-related quality of life in rheumatoid arthritis patients. Modern Rheumatology, 16(6), 601–608.CrossRef
62.
Schmitz, N., & Kruse, J. (2007). The SF-36 summary scores and their relation to mental disorders: Physical functioning may affect performance of the summary scores. Journal of Clinical Epidemiology, 60(2), 163–170.PubMedCrossRef
63.
Wells, K. B., Stewart, A., Hays, R. D., Burnam, M. A., Rogers, W., Daniels, M., et al. (1989). The functioning and well-being of depressed patients. Results from the medical outcomes study. Journal of the American Medical Association, 262(7), 914–919.PubMedCrossRef
64.
Hays, R. D., Wells, K. B., Sherbourne, C. D., Rogers, W., & Spritzer, K. (1995). Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Archives of General Psychiatry, 52(1), 11–19.PubMed
65.
Nettleton, S. (2006). The experience of chronic illness and disability. The sociology of health and illness (2nd ed., pp. 71–103). Cambridge UK: Polity Press.
66.
Paccaloni, M., Rimondini, M., Pozzan, T., & Zimmermann, C. (2008). The communication of the diagnosis of schizophrenia. Focus group findings on psychiatrists’ point of view. Epidemiologica e Psichiatra Sociale, 17(1), 65–76.
Metagegevens
Titel
Implications of long-term conditions for both mental and physical health: comparison of rheumatoid arthritis and schizophrenia
Auteurs
Heidi Lempp
Graham Thornicroft
Morven Leese
Naomi Fearns
Helen Graves
Bernadette Khoshaba
Antonio Lasalvia
David Scott
Michele Tansella
Publicatiedatum
01-08-2009
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 6/2009
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-009-9486-y

Andere artikelen Uitgave 6/2009

Quality of Life Research 6/2009 Naar de uitgave

OriginalPaper

Gender and age differences in domain-specific life satisfaction and the impact of depressive and anxiety symptoms: a general population survey from Germany

OriginalPaper

Health-related quality of life and help seeking among American Indians with diabetes and hypertension

ReviewPaper

The use, feasibility and psychometric properties of an individualised quality-of-life instrument: a systematic review of the SEIQoL-DW

OriginalPaper

Measurement accuracy in assessing patient’s quality of life: to weight or not to weight domains of quality of life

OriginalPaper

Reliability and validity of the SF-12v2 in the medical expenditure panel survey

OriginalPaper

Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample